[33] reported that PKM2 acts as an upstream regulator of the PI3K/AKT signaling pathway; inhibition of PKM2 resulted in diminished PI3K‐Akt–mTOR activity, activation of autophagy, and a reduction in tumor migration. The gene discussed is AKT1; the disease is neoplasm.